Skip to Main Content

Paper Details

Effect of Mastiha supplementation on NAFLD: The MAST4HEALTH Randomised, Controlled Trial.
Mol Nutr Food Res
18
2021
Flavonifractor, LIF, LysoPC, LysoPE, Lysophosphatidylcholines-, Lysophosphatidylethanolamines-, Mastiha, NAFLD, Nonalcoholic fatty liver disease, cholic acid, iron, lipid, liver disease, liver inflammation, microbiota dysbiosis, patient, patients, severely obese
Author NameAffiliation
Stavroula KanoniWilliam Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London
Sophie Visvikis-SiestUMR INSERM U2 IGE-PCV, University of Loraine
Panos DeloukasWilliam Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London
Panos DeloukasQueen Mary University of London
Panos DeloukasWilliam Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London
Panos DeloukasQueen Mary University of London
George DedoussisHarokopio University
  • 1 - 7

Datasets

Release 1.2